Dogwood Therapeutics, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
44 MILTON AVENUE, ALPHARETTA, GA, 30009
Mailing Address
44 MILTON AVENUE, ALPHARETTA, GA, 30009
Phone
8666208655
Fiscal Year End
1231
EIN
854314201
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 10-K Annual financial report | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | February 13, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
Annual Reports
10-K
March 18, 2026
- Strategic pipeline expansion through acquiring Pharmagesic Holdings Inc. and licensing SP16.
- Halneuron, a promising drug candidate for chemotherapy-induced peripheral neuropathy (CIPN) and cancer-related pain, is in Phase 2 clinical trials.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.